Knudsen K A, Rosand J, Karluk D, Greenberg S M
Clinical Trials Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
Neurology. 2001 Feb 27;56(4):537-9. doi: 10.1212/wnl.56.4.537.
The authors performed clinical-pathologic correlation to assess the validity of the Boston diagnostic criteria for cerebral amyloid angiopathy (CAA). Thirteen subjects were diagnosed clinically with probable CAA from among 39 patients with available pathologic tissue in a prospective cohort of subjects aged > or = 55 years with primary lobar hemorrhage. All 13 individuals were confirmed neuropathologically as having CAA. This small pathologic series indicates that the diagnosis of probable CAA can be made during life with high accuracy.
作者进行了临床病理相关性研究,以评估波士顿脑淀粉样血管病(CAA)诊断标准的有效性。在一个年龄≥55岁的原发性脑叶出血前瞻性队列中,39例有可用病理组织的患者中有13例临床诊断为可能的CAA。所有13例患者经神经病理学证实患有CAA。这个小样本病理系列表明,生前诊断可能的CAA具有很高的准确性。